Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Despite continuous research efforts directed at early diagnosis and treatment of pancreatic cancer (PC), the status of patients affected by this deadly malignancy remains dismal. Its notoriety with regard to lack of early diagnosis and resistance to the current chemotherapeutics is due to accumulating signaling abnormalities. Hoarding experimental and epidemiological evidences have established a direct correlation between cigarette smoking and PC risk. The cancer initiating/promoting nature of cigarette smoke can be attributed to its various constituents including nicotine, which is the major psychoactive component, and several other toxic constituents, such as nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and polycyclic aromatic hydrocarbons. These predominant smoke-constituents initiate a series of oncogenic events facilitating epigenetic alterations, self-sufficiency in growth signals, evasion of apoptosis, sustained angiogenesis, and metastasis. A better understanding of the molecular mechanisms underpinning these events is crucial for the prevention and therapeutic intervention against PC. This review presents various interconnected signal transduction cascades, the smoking-mediated genotoxicity, and genetic polymorphisms influencing the susceptibility for smoking-mediated PC development by modulating pivotal biological aspects such as cell defense/tumor suppression, inflammation, DNA repair, as well as tobacco-carcinogen metabolization. Additionally, it provides a large perspective toward tumor biology and the therapeutic approaches against PC by targeting one or several steps of smoking-mediated signaling cascades.

Original languageEnglish (US)
Pages (from-to)1617-1628
Number of pages12
JournalCarcinogenesis
Volume33
Issue number9
DOIs
StatePublished - Sep 1 2012

Fingerprint

Pancreatic Neoplasms
Carcinogenesis
Smoking
Smoke
Early Diagnosis
Neoplasms
Nitrosamines
Poisons
Polycyclic Aromatic Hydrocarbons
Genetic Polymorphisms
Nicotine
Epigenomics
Tobacco Products
DNA Repair
Carcinogens
Tobacco
Signal Transduction
Therapeutics
Apoptosis
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. / Momi, Navneet; Kaur, Sukwinder; Palanimuthu Ponnusamy, Moorthy; Kumar, Sushil; Wittel, Uwe A.; Batra, Surinder Kumar.

In: Carcinogenesis, Vol. 33, No. 9, 01.09.2012, p. 1617-1628.

Research output: Contribution to journalReview article

@article{10a7966e32bb439a99aaf2ec15c50b6e,
title = "Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis",
abstract = "Despite continuous research efforts directed at early diagnosis and treatment of pancreatic cancer (PC), the status of patients affected by this deadly malignancy remains dismal. Its notoriety with regard to lack of early diagnosis and resistance to the current chemotherapeutics is due to accumulating signaling abnormalities. Hoarding experimental and epidemiological evidences have established a direct correlation between cigarette smoking and PC risk. The cancer initiating/promoting nature of cigarette smoke can be attributed to its various constituents including nicotine, which is the major psychoactive component, and several other toxic constituents, such as nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and polycyclic aromatic hydrocarbons. These predominant smoke-constituents initiate a series of oncogenic events facilitating epigenetic alterations, self-sufficiency in growth signals, evasion of apoptosis, sustained angiogenesis, and metastasis. A better understanding of the molecular mechanisms underpinning these events is crucial for the prevention and therapeutic intervention against PC. This review presents various interconnected signal transduction cascades, the smoking-mediated genotoxicity, and genetic polymorphisms influencing the susceptibility for smoking-mediated PC development by modulating pivotal biological aspects such as cell defense/tumor suppression, inflammation, DNA repair, as well as tobacco-carcinogen metabolization. Additionally, it provides a large perspective toward tumor biology and the therapeutic approaches against PC by targeting one or several steps of smoking-mediated signaling cascades.",
author = "Navneet Momi and Sukwinder Kaur and {Palanimuthu Ponnusamy}, Moorthy and Sushil Kumar and Wittel, {Uwe A.} and Batra, {Surinder Kumar}",
year = "2012",
month = "9",
day = "1",
doi = "10.1093/carcin/bgs186",
language = "English (US)",
volume = "33",
pages = "1617--1628",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis

AU - Momi, Navneet

AU - Kaur, Sukwinder

AU - Palanimuthu Ponnusamy, Moorthy

AU - Kumar, Sushil

AU - Wittel, Uwe A.

AU - Batra, Surinder Kumar

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Despite continuous research efforts directed at early diagnosis and treatment of pancreatic cancer (PC), the status of patients affected by this deadly malignancy remains dismal. Its notoriety with regard to lack of early diagnosis and resistance to the current chemotherapeutics is due to accumulating signaling abnormalities. Hoarding experimental and epidemiological evidences have established a direct correlation between cigarette smoking and PC risk. The cancer initiating/promoting nature of cigarette smoke can be attributed to its various constituents including nicotine, which is the major psychoactive component, and several other toxic constituents, such as nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and polycyclic aromatic hydrocarbons. These predominant smoke-constituents initiate a series of oncogenic events facilitating epigenetic alterations, self-sufficiency in growth signals, evasion of apoptosis, sustained angiogenesis, and metastasis. A better understanding of the molecular mechanisms underpinning these events is crucial for the prevention and therapeutic intervention against PC. This review presents various interconnected signal transduction cascades, the smoking-mediated genotoxicity, and genetic polymorphisms influencing the susceptibility for smoking-mediated PC development by modulating pivotal biological aspects such as cell defense/tumor suppression, inflammation, DNA repair, as well as tobacco-carcinogen metabolization. Additionally, it provides a large perspective toward tumor biology and the therapeutic approaches against PC by targeting one or several steps of smoking-mediated signaling cascades.

AB - Despite continuous research efforts directed at early diagnosis and treatment of pancreatic cancer (PC), the status of patients affected by this deadly malignancy remains dismal. Its notoriety with regard to lack of early diagnosis and resistance to the current chemotherapeutics is due to accumulating signaling abnormalities. Hoarding experimental and epidemiological evidences have established a direct correlation between cigarette smoking and PC risk. The cancer initiating/promoting nature of cigarette smoke can be attributed to its various constituents including nicotine, which is the major psychoactive component, and several other toxic constituents, such as nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and polycyclic aromatic hydrocarbons. These predominant smoke-constituents initiate a series of oncogenic events facilitating epigenetic alterations, self-sufficiency in growth signals, evasion of apoptosis, sustained angiogenesis, and metastasis. A better understanding of the molecular mechanisms underpinning these events is crucial for the prevention and therapeutic intervention against PC. This review presents various interconnected signal transduction cascades, the smoking-mediated genotoxicity, and genetic polymorphisms influencing the susceptibility for smoking-mediated PC development by modulating pivotal biological aspects such as cell defense/tumor suppression, inflammation, DNA repair, as well as tobacco-carcinogen metabolization. Additionally, it provides a large perspective toward tumor biology and the therapeutic approaches against PC by targeting one or several steps of smoking-mediated signaling cascades.

UR - http://www.scopus.com/inward/record.url?scp=84865543465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865543465&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgs186

DO - 10.1093/carcin/bgs186

M3 - Review article

C2 - 22623649

AN - SCOPUS:84865543465

VL - 33

SP - 1617

EP - 1628

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -